HCW Biologics Inc.
↗Miramar, Florida, USA
HCW Biologics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company operates in the field of 'inflammaging,' targeting unresolved inflammatory responses that contribute to cancer, cardiovascular disease, diabetes, neurodegenerative disorders, and autoimmune conditions.
The company leverages two proprietary discovery platforms: TOBI™ (Tissue factOr-Based fusIon) and TRBC (T-cell Receptor β Chain constant region). These platforms enable the design of multi-functional fusion molecules that can simultaneously activate immune responses and target specific diseased cells. HCW Biologics is currently advancing a pipeline of over 50 molecules, with lead candidates in clinical trials for oncology and autoimmune indications.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Immunotherapy and Oncology Biotech
SIZE & FINANCIALS
Employees:1-50
Revenue:$0M-$5M
Founded:2018
Ownership:public
Status:operating
FUNDING
Stage:Post-IPO
Total Raised:$66.5M
Investors:DeepWork Capital, Florida Opportunity Fund, Maxim Group LLC (Placement Agent)
STOCK
Exchange:NASDAQ
Ticker:HCWB
Market Cap:$2.13M
PIPELINE
Stage:Phase 2
Lead Drug Stage:Phase 1b/2
Modalities:Fusion protein, mAb, T-cell engager, Immune checkpoint inhibitor
Active Trials:3
Trial Phases:Phase 1: 2 | Phase 2: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Beijing Trimmune Biotech Co., Ltd. (Joint Venture)
Key Partnerships:Wugen Inc. (Licensing for cell therapy manufacturing), WY Biotech (Joint venture and licensing for HCW11-006), Albert Einstein College of Medicine (Research collaboration)
COMPETITION
Position:Emerging
Competitors:Gilead Sciences, Merck & Co., AbbVie, Intercept Pharmaceuticals, Pliant Therapeutics, ImmunityBio
LEADERSHIP
Key Executives:
Hing C. Wong, Ph.D. - Founder and CEO
Peter Rhode, Ph.D. - Chief Scientific Officer
Rebecca Byam - Chief Financial Officer
Scientific Founders:Hing C. Wong, Ph.D.
Board Members:Scott T. Garrett (Independent Chairman), Hing C. Wong, Ph.D., Lisa Giles, Richard Greene
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with HCW Biologics Inc.. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.